Literature DB >> 9783197

[Metastatic renal tumor originating from esophageal carcinoma: a case report].

Y Matsushita1, T Katoh, K Isurugi, W Obara, T Suzuki, T Tamura, S Tanji, T Fujioka.   

Abstract

We report a case of renal metastasis from esophageal carcinoma. The patient was a 74-year-old man, who had undergone an operation for esophageal carcinoma thirteen months previously. He was admitted to our clinic for examination of a right renal mass. Computed tomography (CT) revealed an irregular low density area in the right kidney and angiography showed a hypovascular tumor. Partial nephrectomy was performed. Histological examination revealed squamous cell carcinoma and the diagnosis was metastasis of esophageal carcinoma. Metastatic renal tumors are rarely encountered clinically and, to our knowledge, the present case is only the 16th clinical report of the renal metastasis of esophageal carcinoma in Japan. However, metastasis to the kidney is relatively common at autopsy. It is the fifth most common site of metastasis following the lungs, liver, bones and adrenals. Consequently, patients with malignancy should be followed up while keeping renal metastasis in mind.

Entities:  

Mesh:

Year:  1998        PMID: 9783197

Source DB:  PubMed          Journal:  Hinyokika Kiyo        ISSN: 0018-1994


  3 in total

1.  Solitary renal metastasis of esophageal squamous cell carcinoma mimicking primary renal neoplasm - A case report and literature review.

Authors:  Kai-Po Chang; Chi-Ping Huang; Han Chang
Journal:  Biomedicine (Taipei)       Date:  2016-02-10

Review 2.  Renal metastasis after esophagectomy of esophageal squamous cell carcinoma: a case report and literature review.

Authors:  Yan Sun; Xinmin Yu; Yiping Zhang
Journal:  World J Surg Oncol       Date:  2014-05-26       Impact factor: 2.754

3.  Synchronous and metachronous metastasis to renal parenchyma of esophageal squamous cell carcinoma: two case reports and review of the literature.

Authors:  Jun Jia; Wei Sun; Dongmei Lin; Xiaodong Zhang
Journal:  Transl Cancer Res       Date:  2021-02       Impact factor: 1.241

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.